| Business Name: |
Elfenbein Emanuel MD |
| Contact Person: |
Emanuel Elfenbein |
| Address: |
204 Eagle Rock Avenue, Roseland, New Jersey 07068 |
| Phone Number: |
(973) 228-8943 |
| Annual Revenue (USD): |
$500.000 to $999.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
6211110 |
| Share This Business: |
|
| Related Businesses: |
Dispute Doctors - Roseland, NJ 07068
Gorman Eugene S MD - Roseland, NJ 07068
Mintz Shari N MD - Roseland, NJ 07068
Makhlouf Jean MD - Roseland, NJ 07068
Klein Richard L MD - Roseland, NJ 07068
Weinberger Daniela MD - Roseland, NJ 07068
Rutgers The State University Of New Jersey - Roseland, NJ 07068
Fischer Jr Edward DC - Roseland, NJ 07068
Di Trolio Joseph V - Roseland, NJ 07068
Caputo Anthony R MD - Roseland, NJ 07068
Richard Schenk Md - Roseland, NJ 07068
Kopacz Kenneth J MD - Roseland, NJ 07068
Turbin Roger E MD - Roseland, NJ 07068
Ioffe Inna S MD - Roseland, NJ 07068
Jared Sullivan LLC - Roseland, NJ 07068
Mamoun Plastic Surgery - Roseland, NJ 07068
Anello Tiziana MD - Roseland, NJ 07068
Smith Stephen M MD - Roseland, NJ 07068
Assoc of Infectious Disease - Roseland, NJ 07068
Essex Endocrine Assoc - Roseland, NJ 07068
|
The company Elfenbein Emanuel MD provides B2C services in the form of Doctors from its single location in New Jersey.
1 to 4 employees work for Elfenbein Emanuel MD, and the business now earns $500.000 to $999.999 per annum.
Elfenbein Emanuel MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Elfenbein Emanuel MD, please call Emanuel Elfenbein with the phone number (973) 228-8943 or visit its single location at 204 Eagle Rock Avenue in Roseland, New Jersey 07068.
The location of the single location can also be found using the coordinates 40.82108,-74.29748.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.